Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands |
Total |
Common Stock |
Additional Paid-In Capital |
Accumulated Other Comprehensive Loss |
Accumulated Deficit |
Beginning Balance at Dec. 31, 2021 |
$ 368,197
|
$ 6
|
$ 596,934
|
$ (269)
|
$ (228,474)
|
Beginning Balance, Shares at Dec. 31, 2021 |
|
51,569,381
|
|
|
|
Exercise of stock options |
18
|
|
18
|
|
|
Exercise of stock options, Shares |
|
9,583
|
|
|
|
Stock-based compensation |
4,488
|
|
4,488
|
|
|
Vesting of restricted shares |
|
20,504
|
|
|
|
Vesting of restricted stock units |
|
49,955
|
|
|
|
Unrealized gain on marketable securities |
(661)
|
|
|
(661)
|
|
Net loss |
(35,583)
|
|
|
|
(35,583)
|
Ending Balance at Mar. 31, 2022 |
336,459
|
$ 6
|
601,440
|
(930)
|
(264,057)
|
Ending Balance, Shares at Mar. 31, 2022 |
|
51,649,423
|
|
|
|
Beginning Balance at Dec. 31, 2021 |
368,197
|
$ 6
|
596,934
|
(269)
|
(228,474)
|
Beginning Balance, Shares at Dec. 31, 2021 |
|
51,569,381
|
|
|
|
Unrealized gain on marketable securities |
(714)
|
|
|
|
|
Net loss |
(129,272)
|
|
|
|
|
Ending Balance at Sep. 30, 2022 |
249,744
|
$ 6
|
608,467
|
(983)
|
(357,746)
|
Ending Balance, Shares at Sep. 30, 2022 |
|
51,906,773
|
|
|
|
Beginning Balance at Mar. 31, 2022 |
336,459
|
$ 6
|
601,440
|
(930)
|
(264,057)
|
Beginning Balance, Shares at Mar. 31, 2022 |
|
51,649,423
|
|
|
|
Exercise of stock options |
99
|
|
99
|
|
|
Exercise of stock options, Shares |
|
32,367
|
|
|
|
Stock-based compensation |
3,031
|
|
3,031
|
|
|
Vesting of restricted shares |
|
10,664
|
|
|
|
Vesting of restricted stock units |
|
41,907
|
|
|
|
Unrealized gain on marketable securities |
(226)
|
|
|
(226)
|
|
Net loss |
(52,304)
|
|
|
|
(52,304)
|
Ending Balance at Jun. 30, 2022 |
287,059
|
$ 6
|
604,570
|
(1,156)
|
(316,361)
|
Ending Balance, Shares at Jun. 30, 2022 |
|
51,734,361
|
|
|
|
Exercise of stock options |
70
|
|
70
|
|
|
Exercise of stock options, Shares |
|
19,354
|
|
|
|
Stock-based compensation |
3,827
|
|
3,827
|
|
|
Vesting of restricted shares |
|
4,511
|
|
|
|
Vesting of restricted stock units |
|
148,547
|
|
|
|
Unrealized gain on marketable securities |
173
|
|
|
173
|
|
Net loss |
(41,385)
|
|
|
|
(41,385)
|
Ending Balance at Sep. 30, 2022 |
249,744
|
$ 6
|
608,467
|
(983)
|
(357,746)
|
Ending Balance, Shares at Sep. 30, 2022 |
|
51,906,773
|
|
|
|
Beginning Balance at Dec. 31, 2022 |
252,364
|
$ 6
|
649,502
|
(571)
|
(396,573)
|
Beginning Balance, Shares at Dec. 31, 2022 |
|
55,636,505
|
|
|
|
Issuance of stock, net of issuance costs |
28,186
|
|
28,186
|
|
|
Issuance of stock, net of issuance costs, Shares |
|
2,335,150
|
|
|
|
Exercise of stock options |
587
|
|
587
|
|
|
Exercise of stock options, Shares |
|
232,292
|
|
|
|
Stock-based compensation |
4,617
|
|
4,617
|
|
|
Vesting of restricted shares |
|
101,533
|
|
|
|
Unrealized gain on marketable securities |
368
|
|
|
368
|
|
Net loss |
(44,187)
|
|
|
|
(44,187)
|
Ending Balance at Mar. 31, 2023 |
241,935
|
$ 6
|
682,892
|
(203)
|
(440,760)
|
Ending Balance, Shares at Mar. 31, 2023 |
|
58,305,480
|
|
|
|
Beginning Balance at Dec. 31, 2022 |
$ 252,364
|
$ 6
|
649,502
|
(571)
|
(396,573)
|
Beginning Balance, Shares at Dec. 31, 2022 |
|
55,636,505
|
|
|
|
Exercise of stock options, Shares |
790,379
|
|
|
|
|
Unrealized gain on marketable securities |
$ 558
|
|
|
|
|
Net loss |
(169,299)
|
|
|
|
|
Ending Balance at Sep. 30, 2023 |
152,038
|
$ 6
|
717,917
|
(13)
|
(565,872)
|
Ending Balance, Shares at Sep. 30, 2023 |
|
61,322,283
|
|
|
|
Beginning Balance at Mar. 31, 2023 |
241,935
|
$ 6
|
682,892
|
(203)
|
(440,760)
|
Beginning Balance, Shares at Mar. 31, 2023 |
|
58,305,480
|
|
|
|
Issuance of stock, net of issuance costs |
24,184
|
|
24,184
|
|
|
Issuance of stock, net of issuance costs, Shares |
|
2,173,913
|
|
|
|
Exercise of stock options |
764
|
|
764
|
|
|
Exercise of stock options, Shares |
|
432,626
|
|
|
|
Stock-based compensation |
4,749
|
|
4,749
|
|
|
Vesting of restricted shares |
|
101,967
|
|
|
|
Unrealized gain on marketable securities |
147
|
|
|
147
|
|
Net loss |
(64,902)
|
|
|
|
(64,902)
|
Ending Balance at Jun. 30, 2023 |
206,877
|
$ 6
|
712,589
|
(56)
|
(505,662)
|
Ending Balance, Shares at Jun. 30, 2023 |
|
61,013,986
|
|
|
|
Exercise of stock options |
453
|
|
453
|
|
|
Exercise of stock options, Shares |
|
125,461
|
|
|
|
Stock-based compensation |
4,875
|
|
4,875
|
|
|
Vesting of restricted shares |
|
182,836
|
|
|
|
Unrealized gain on marketable securities |
43
|
|
|
43
|
|
Net loss |
(60,210)
|
|
|
|
(60,210)
|
Ending Balance at Sep. 30, 2023 |
$ 152,038
|
$ 6
|
$ 717,917
|
$ (13)
|
$ (565,872)
|
Ending Balance, Shares at Sep. 30, 2023 |
|
61,322,283
|
|
|
|